Katelyn Whyte Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 Timothy Trl S, Easton, PA 18040 Phone: 610-905-5946 |
Janet Ann Gallagher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Northampton St, Easton, PA 18045 Phone: 610-250-0150 |
Pauline Lopez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2640 Fringe Ln, Easton, PA 18040 Phone: 484-892-7598 |
Katie Kittle, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2673 Northwood Ave, Easton, PA 18045 Phone: 201-207-3649 |
Sarah Benjamin Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2591 Chestnut Ln, Easton, PA 18040 Phone: 814-441-0807 |
Nicole Skibbee, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 147 S 4th St Apt 5, Easton, PA 18042 Phone: 908-303-2997 |
Emily Doll, M.A. M.S. CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1011 George St Apt 8e, Easton, PA 18040 Phone: 484-695-0640 |
Mr. Timothy Stewart Murch, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 327 Porter St, Easton, PA 18042 Phone: 415-378-9408 |
Miss Kalyn Ashley Rupert, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1011 Frost Hollow Rd, Easton, PA 18040 Phone: 610-392-4326 |
Jenna Moravec, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2222 Sullivan Trl, Easton, PA 18040 Phone: 610-991-2034 |
Laura Regan White, SLP-CCC Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2222 Sullivan Trl, Easton, PA 18040 Phone: 800-944-9782 |
Sandra Blickensderfer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Danforth Rd, Easton, PA 18045 Phone: 610-252-5550 |
Olivia Alexis Brown, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Sullivan Trl, Easton, PA 18040 Phone: 610-991-2034 |
Melanie Palacios-sajonas, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 215 Cedar Park Blvd, Easton, PA 18042 Phone: 610-438-2662 |
Mrs. Jennifer Morgan Smith, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 110 Jeremy Ct, Easton, PA 18045 Phone: 484-903-9719 |
Melissa Bornstein, M.S. CCC-SLP, M.H.A. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 821 Spring Garden St, Easton, PA 18042 Phone: 484-240-1238 |
Katelyn Victoria Whyte, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 311 W Lafayette St, Easton, PA 18042 Phone: 610-905-5946 |
Wendy K Taylor, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2222 Sullivan Trl, Easton, PA 18040 Phone: 610-991-2034 Fax: 610-438-2046 |
Nancy Hofmann Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6 Danforth Stive, Easton, PA 18045 Phone: 610-252-5550 |
Holly Hendershot Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2040 Washington Blvd, Easton, PA 18042 Phone: 484-373-6000 |
News Archive
A study from Thomson Reuters released today shows despite world-class universities, established government laboratories and several Nobel Prizes, Japan's performance in scientific research has remained mostly static.
Naturally occurring arsenic in private wells threatens people in many U.S. states and parts of Canada, according to a package of a dozen scientific papers to be published next week. The studies, focused mainly on New England but applicable elsewhere, say private wells present continuing risks due to almost nonexistent regulation in most states, homeowner inaction and inadequate mitigation measures.
A steady decline over more than two decades has resulted in a 25% drop in the overall cancer death rate in the United States. The drop equates to 2.1 million fewer cancer deaths between 1991 and 2014.
Star Scientific, Inc. announced that on Friday, February 19 the company filed an application with the Food & Drug Administration for approval to market Ariva-BDLâ„¢ as a "modified risk" tobacco product under the Family Smoking Prevention and Tobacco Control Act of 2009. This submission is the first such application to be filed with the Tobacco Products Center of the FDA, which has been established to oversee all aspects of tobacco regulation outlined in the 2009 Act.
› Verified 1 days ago